Reports by quarter

Reports submitted in 2026-Q2 · page 20

Buyer-sourced sensitivity analysis added to every supplier scorecard. Median purity for the quarter is 98.90 % area, n=1009. Read the 2026-Q2 state-of-the-index report →

1,009 records26 pagesmedian on this page 98.75 %updated 30 Jul 2026

Report	Compound	Supplier	Lot	Lab	Quarter	Purity %	Water %	Recovery %	Provenance	Flags	Result
AX-2026-042848	Retatrutide	GGPeps	GGPE-2511-X1688	Janoshik	2026-Q2	98.64	5.38	—	Supplier-supplied	2	MARGINAL
AX-2026-042756	TB-500	GGPeps	GGPE-2601-B9932	Medutest	2026-Q2	99.79	4.79	—	Supplier-supplied	1	MARGINAL
AX-2026-042644	IGF-1 LR3	GGPeps	GGPE-2604-K8140	PeptideMeter	2026-Q2	98.36	2.46	109.0	Supplier-supplied	0	PASS
AX-2026-042594	Tirzepatide	GGPeps	GGPE-2604-H8313	Kestrel	2026-Q2	99.93	1.87	—	Supplier-supplied	1	MARGINAL
AX-2026-041802	Tirzepatide	FGP	FGP-2605-R1831	Medutest	2026-Q2	98.07	6.43	—	Supplier-supplied	2	MARGINAL
AX-2026-041621	BPC-157	QSC	QSC-2511-N8732	Janoshik	2026-Q2	99.93	5.60	96.0	Supplier-supplied	1	MARGINAL
AX-2026-041595	TB-500	QSC	QSC-2601-V7307	VendorInvestigate	2026-Q2	99.54	3.91	99.5	Buyer-sourced	1	MARGINAL
AX-2026-041532	BPC-157	QYB	QYB-2601-H6381	Janoshik	2026-Q2	99.93	2.43	—	Supplier-supplied	1	MARGINAL
AX-2026-041435	BPC-157	QYB	QYB-2601-D4733	Janoshik	2026-Q2	99.93	3.77	96.6	Supplier-supplied	0	PASS
AX-2026-041393	Adipotide	WWB	WWB-2512-R4093	VendorInvestigate	2026-Q2	98.32	3.35	98.7	Buyer-sourced	1	MARGINAL
AX-2026-041226	Thymulin	WWB	WWB-2602-S2129	Janoshik	2026-Q2	99.36	4.19	88.6	Supplier-supplied	2	MARGINAL
AX-2026-043532	MK-677 (Ibutamoren mesylate)	BCH	BCH-2511-G7276	Janoshik	2026-Q2	98.18	4.32	—	Laboratory-retained	1	FAIL
AX-2026-043476	GHRP-6	WXT	WXT-2604-M5964	VendorInvestigate	2026-Q2	98.18	3.83	—	Buyer-sourced	1	FAIL
AX-2026-042940	CJC-1295 (no DAC)	MKM	MKM-2512-Y3111	Janoshik	2026-Q2	97.49	4.60	106.5	Supplier-supplied	2	FAIL
AX-2026-042787	Selank	GGPeps	GGPE-2601-J1391	Janoshik	2026-Q2	99.37	9.27	—	Supplier-supplied	0	PASS
AX-2026-042695	Retatrutide	GGPeps	GGPE-2512-D9394	Janoshik	2026-Q2	98.19	3.76	—	Supplier-supplied	1	MARGINAL
AX-2026-042653	Semax	GGPeps	GGPE-2602-Y8213	Janoshik	2026-Q2	99.09	5.66	—	Supplier-supplied	0	PASS
AX-2026-042455	NAD+	SWB	SWB-2602-P5992	Janoshik	2026-Q2	99.22	10.60	—	Supplier-supplied	1	FAIL
AX-2026-042293	BPC-157	HJ	HJ-2511-P2829	Kestrel	2026-Q2	99.86	3.77	105.1	Supplier-supplied	0	PASS
AX-2026-042158	GHRP-2	Homopeptide	HOMO-2602-E9033	Janoshik	2026-Q2	99.59	4.35	89.8	Buyer-sourced	2	MARGINAL
AX-2026-041949	Semax	TFC	TFC-2602-F4591	VendorInvestigate	2026-Q2	98.74	9.12	99.9	Buyer-sourced	0	PASS
AX-2026-041858	ARA-290	JEEP	JEEP-2601-K3139	VendorInvestigate	2026-Q2	98.82	4.14	—	Buyer-sourced	1	MARGINAL
AX-2026-041855	ARA-290	JEEP	JEEP-2601-K3139	Janoshik	2026-Q2	99.21	4.41	—	Supplier-supplied	1	MARGINAL
AX-2026-041614	GHRP-6	QSC	QSC-2605-A7936	Janoshik	2026-Q2	99.93	4.48	90.2	Supplier-supplied	0	PASS
AX-2026-041604	Enclomiphene citrate	QSC	QSC-2604-R7865	Janoshik	2026-Q2	99.93	4.22	—	Supplier-supplied	0	FAIL
AX-2026-041398	Adipotide	WWB	WWB-2512-R4093	Janoshik	2026-Q2	98.57	2.94	105.0	Laboratory-retained	1	MARGINAL
AX-2026-043511	MGF	BCH	BCH-2511-D7240	Janoshik	2026-Q2	98.69	6.01	—	Supplier-supplied	0	PASS
AX-2026-043271	Hexarelin	CPC	CPC-2511-F1491	Janoshik	2026-Q2	98.35	5.33	102.6	Buyer-sourced	2	FAIL
AX-2026-043092	Epitalon	KP	KP-2512-R5829	Janoshik	2026-Q2	98.63	6.87	—	Supplier-supplied	2	FAIL
AX-2026-043011	Tirzepatide	KP	KP-2602-X5446	Kestrel	2026-Q2	98.90	6.40	101.8	Supplier-supplied	1	MARGINAL
AX-2026-043008	Tirzepatide	KP	KP-2602-X5446	Nordanalyt	2026-Q2	98.44	6.37	105.1	Supplier-supplied	1	MARGINAL
AX-2026-043001	TB-500	KP	KP-2605-C4659	Medutest	2026-Q2	99.33	5.74	—	Supplier-supplied	2	MARGINAL
AX-2026-042898	Semax	MKM	MKM-2512-B2992	PeptideMeter	2026-Q2	98.48	6.39	104.4	Supplier-supplied	1	FAIL
AX-2026-042814	GHRP-6	GGPeps	GGPE-2605-U1620	Janoshik	2026-Q2	98.75	6.22	95.6	Supplier-supplied	2	FAIL
AX-2026-042566	Tirzepatide	ERP	ERP-2512-T7433	Medutest	2026-Q2	99.36	1.63	99.6	Supplier-supplied	2	MARGINAL
AX-2026-042431	IGF-1 DES (1-3)	SWB	SWB-2601-Y5870	Janoshik	2026-Q2	98.27	4.14	—	Supplier-supplied	1	MARGINAL
AX-2026-042283	Semaglutide	Homopeptide	HOMO-2604-M2254	Janoshik	2026-Q2	98.50	2.58	—	Laboratory-retained	1	MARGINAL
AX-2026-042018	Liraglutide	TFC	TFC-2511-E6528	Janoshik	2026-Q2	98.29	3.61	—	Supplier-supplied	0	PASS
AX-2026-042017	Liraglutide	TFC	TFC-2511-E6528	Medutest	2026-Q2	98.38	3.92	103.5	Supplier-supplied	0	PASS
AX-2026-041854	ARA-290	JEEP	JEEP-2601-K3139	VendorInvestigate	2026-Q2	98.69	3.84	107.0	Buyer-sourced	1	MARGINAL